Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.59 |
| ▸ | CNR1 | P21554 | 1/20 | 0.57 |
| ▸ | CNR2 | P34972 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1835355 | 1.00 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL1840168 | 1.00 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL1839719 | 1.00 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL1840086 | 1.00 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL1837153 | 1.00 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL1837219 | 1.00 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL1836768 | 1.00 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL1833744 | 1.00 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL1833842 | 1.00 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1GPR84 | |
| SCHEMBL1837800 | 1.00 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030170549-A1 | Non-aqueous electrolyte battery | JAPAN STORAGE BATTERY CO., LTD. | 2003-09-11 | — | — | US | claimed |
| CN-122055369-A | Bridged tricyclic carbamoyl pyridone compounds and uses thereof | 吉利德科学公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-119998421-A | Sealant resin composition and use thereof | 三井化学株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-118412540-A | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2024-07-30 | — | — | CN | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| WO-2024053644-A1 | SEALANT RESIN COMPOSITION AND USE OF SAME | 三井化学株式会社 | 2024-03-14 | — | — | WO | disclosed |
| CN-116982190-A | Nonaqueous secondary battery and method for manufacturing nonaqueous secondary battery | 三井化学株式会社 | 2023-10-31 | — | — | CN | disclosed |
| WO-2023186023-A1 | N-SUBSTITUTED QUINOLINONE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州旺山旺水生物医药股份有限公司 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-11597736-B2 | Lithium boron fluorophosphate complex compound, lithium boron fluorophosphate-containing composition, lithium boron fluorophosphate, additive for lithium secondary battery, non-aqueous electrolytic solution for battery, and lithium secondary battery | MITSUI CHEMICALS, INC. (JP) | 2023-03-07 | — | — | US | disclosed |
| EP-2322504-A1 | PROCESS FOR THE PREPARATION OF N-SUBSTITUTED CARBAMIC ACID ESTER AND PROCESS FOR THE PREPARATION OF ISOCYANATE USING THE N-SUBSTITUTED CARBAMIC ACID ESTER | Asahi Kasei Chemicals Corporation (JP) | 2011-05-18 | — | — | EP | disclosed |
| CN-101808616-A | Hair dye and hair dye composition | HODOGAYA CHEMICAL CO LTD | 2010-08-18 | — | — | CN | disclosed |
| EP-2193781-A1 | HAIR DYE AND HAIR DYE COMPOSITION | Hodogaya Chemical Co., Ltd. (JP) | 2010-06-09 | — | — | EP | disclosed |
| CN-1287480-C | Nonaqueous electrlyte for lithium battery and lithium ion secondary battery | MITSUI CHEMICALS INC (JP) | 2006-11-29 | — | — | CN | disclosed |
| CN-1540793-A | Nonaqueous electrlyte for lithium battery and lithium ion secondary battery | 三井化学株式会社 | 2004-10-27 | — | — | CN | disclosed |
| US-20030170549-A1 | Non-aqueous electrolyte battery | JAPAN STORAGE BATTERY CO., LTD. | 2003-09-11 | — | — | US | disclosed |
| US-6482418-B1 | SUBSTITUTES FOR SILICONE OILS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-11-19 | — | — | US | disclosed |
| US-6475680-B1 | Lithium secondary battery, its electrolyte, and electric apparatus using the same | HITACHI, LTD. (JP) | 2002-11-05 | — | — | US | disclosed |
| US-6204229-B1 | PERFUME RETENTIVITY | KAO CORPORATION (JP) | 2001-03-20 | — | — | US | disclosed |
| EP-0944126-A1 | Lithium secondary battery, its electrolyte, and electric apparatus using the same | Hitachi, Ltd. (JP) | 1999-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11597736-B2 | Lithium boron fluorophosphate complex compound, lithium boron fluorophosphate-containing composition, lithium boron fluorophosphate, additive for lithium secondary battery, non-aqueous electrolytic solution for battery, and lithium secondary battery | F9, BCL9L, SLC9B2 | FAAH 2279/4885CNR1 4116/4885CNR2 4060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.